SCAI releases consensus guidelines for PVD device selection

April 25, 2018

SAN DIEGO - The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the selection of specific categories of devices when endovascular therapy (EVT) is indicated. The purpose of this document, which is the first of its kind, is to provide a review of comparative effectiveness data, including safety and efficacy of femoral-popliteal (FP) devices, and to provide clinicians with guidance and recommendations for device selection when these devices are intended as the definitive or adjunctive therapy. The document is available in early-view online in SCAI's official journal, Catheterization and Cardiovascular Interventions.

There is widespread uncertainty about device selection for EVT due to clinicians having many options and opinions with limited data to distinguish between them. The SCAI writing group reviewed and considered data on safety, efficacy, and cost-effectiveness when making device-specific recommendations. Data sources included randomized clinical trials, meta-analyses, nonrandomized trials, observational studies, case series and registry data.

"SCAI has a long history of prioritizing quality initiatives in the field of endovascular therapy for peripheral artery disease. Device choices for endovascular therapy, particularly in the femoral-popliteal interventions, remain challenging due to a wide spectrum of available device options and a paucity of comparative effectiveness data," said Dmitriy Feldman, MD, FSCAI, chair of the writing group. "Current guidelines do not address the selection of specific devices when endovascular therapy is indicated. This is the first SCAI-led device-focused consensus guidelines document, which provides a focused review of comparative effectiveness and safety data for femoral-popliteal devices," Dr. Feldman continued.

The document, which makes recommendations for both definitive and adjunctive therapy scenarios, identified several areas for future research, including trials on value and cost-effectiveness of devices in specific clinical circumstances and lesion subsets. In addition, the guidelines recommend that future studies adopt the Peripheral Academic Research Consortium (PARC) definitions for clinically meaningful outcomes and endpoints. The recommendations in this consensus guidelines document are a first step to provide clinicians with relevant anatomical scenarios to guide device selection based on strength and quality of evidence for comparative effectiveness, durability, and expert opinion.
-end-
About SCAI

The Society for Cardiovascular Angiography and Interventions is a 4,200-member professional organization representing invasive and interventional cardiologists in approximately 75 countries. SCAI's mission is to promote excellence in invasive/interventional cardiovascular medicine through physician and allied health professional education and representation, and advancement of quality standards to enhance patient care. For more information about SCAI, visit http://www.SCAI.org. Follow @SCAI on Twitter for the latest heart health news.

Society for Cardiovascular Angiography and Interventions

Related Safety Articles from Brightsurf:

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

How EU safety legislation has affected UK vapers
New research shows that vapers have been largely reassured by recent EU regulations, but some have been pushed to the black market for stronger hits.

Tunnel fire safety
With only minutes to respond, fire education really counts.

New study supports the safety of varenicline
A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix and Champix) does not appear to be associated with an increased risk of cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapy (NRT).

Advancing frozen food safety: Cornell develops novel food safety assessment tool
New research funded by the Frozen Food Foundation developed a modeling tool to assist the frozen food industry with understanding and managing listeriosis risks.

'Safety signals' may help slow down anxiety
For as many as one in three people, life events or situations that pose no real danger can spark a disabling fear, a hallmark of anxiety and stress-related disorders.

UQ researcher carving a new path for skier safety
A spectacular stack on a ski slope in Canada has led to a University of Queensland researcher determining a simple modification that could improve skier safety on the snow.

Nanomaterial safety on a nano budget
A Rice University laboratory develops and shares a low-cost method to safely handle the transfer of bulk carbon nanotubes and other nanomaterials.

Drexel-developed safety climate scale helps fire departments reach safety goals
A new safety scale, that effectively measures the safety climate of a fire department, has been developed by researchers from Drexel's Dornsife School of Public Health, according to a paper published today in the journal Safety Science.

Safety of overlapping surgeries
Overlapping surgeries, in which more than one procedure is performed by the same surgeon working in different operating rooms, have raised concerns about potential adverse outcomes.

Read More: Safety News and Safety Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.